The global market for cancer in vitro diagnostic products reached 8 billion in 2012

Release date: 2008-04-08

The global market for cancer in vitro diagnostic products reached 8 billion in 2012
Kalorama Information Corporation released the latest market analysis report, thanks to the development of biomarkers and a number of related innovation research, in 2012, the global market for cancer in vitro diagnostic products will reach 8 billion US dollars, with an annual growth rate of nearly 11%. In addition to the positive impacts of demographic factors and epidemiological trends on this market, new advances in traditional technologies, good biomarker developments, and clinical requirements are also driving the market's rise. The report shows that the increasing level of cancer screening, the emphasis on cancer detection in public health, and the increased focus on medical costs in medical practice are all about the development and use of basic cancer screening and detection technologies. An important influence has been made, such as the application of fecal occult blood test in colorectal cancer screening. According to the report, the continuous development of drug diagnostic technologies aimed at helping to develop better treatment programs, and the genetic and molecular detection technologies for assessing the risk of cancer in patients, provide opportunities for the development of in vitro detection products for cancer, as well as Helping the formation of emerging markets in this sector. In addition to technical factors, from a medical point of view, cancer as a new perspective of chronic diseases is also a positive factor for R&D manufacturers. With the continuous advancement of cancer diagnosis and treatment methods, more product demand will appear in cancer treatment monitoring. . At present, the most exciting aspect of the market for cancer in vitro diagnostic products is the high level of collaboration of various technologies. The result will complicate the source of new products. Some cancer in vitro diagnostic products are likely to come from information technology vendors and Diagnostic reagent manufacturers also include various technology platforms, such as imaging equipment manufacturers. ——Midi Medical Network

Our company has been in this line of business for more than 13 years, with its location superiority and rich experience, the garlic and ginger are our main products. As we all know, jinxiang is famous for garlic around the world, our factory of garlic also located in jinxiang. We are committed to consistently providing fresh, safe, high quality garlic from the planting, processing and cold-storing. We operate and control strictly from planting and processing to supply superior quality and nature products. Honest, top quality, best service, our company earned the good reputation from our customer and established the long term relationship with the customer all over the world.Except Fresh Garlic ,we also supplied Fresh Ginger , Air Dried Ginger , Fresh Onion , Peeled Onion , Fresh Chestnut , Sweet Corn , Fresh Taro , Fresh Potato , Fresh Baby Mandarin, Fresh Red Grape, Fresh Pomelo , Fresh Ya Pear   Chaotian Chili , Paprika Powder , Fresh Apple and so on.

Normal White Garlic 4.5-5.0Cm

Normal White Garlic 4.5-5.0Cm,Natural Garlic,White Garlic,4.5Cm Normal White Garlic

Jining Fuyuan Fruits And Vegetables Co., Ltd. , https://www.fuyuanfv.com